Francesco Passamonti, MD, University of Insubria, Varese, Italy, gives an overview of treatment options available for patients with myelofibrosis (MF) and anemia, including momelotinib, pacritinib, and combinations with ruxolitinib. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.